Intraspecies Transmission of BASE Induces Clinical Dullness and Amyotrophic Changes by Lombardi, Guerino et al.
Intraspecies Transmission of BASE Induces Clinical
Dullness and Amyotrophic Changes
Guerino Lombardi
1, Cristina Casalone
2, Antonio D’ Angelo
3, Daniela Gelmetti
1, Gloria Torcoli
1, Ilaria
Barbieri
1, Cristiano Corona
2, Elisa Fasoli
4, Alessia Farinazzo
4, Michele Fiorini
4, Matteo Gelati
4, Barbara
Iulini
2, Fabrizio Tagliavini
5, Sergio Ferrari
4, Maria Caramelli
2, Salvatore Monaco
4, Lorenzo Capucci
1,
Gianluigi Zanusso
4*
1Istituto Zooprofilattico Sperimentale della Lombardia e dell’ Emilia Romagna, Brescia, Italy, 2Centro di Referenza Nazionale per le Encefalopatie Animali, Istituto
Zooprofilattico Sperimentale del Piemonte, Liguria e Valle D’ Aosta, Turin, Italy, 3Dipartimento di Patologia Animale, Universita ` degli Studi di Torino, Grugliasco, Italy,
4Department of Neurological and Visual Sciences, Section of Clinical Neurology, University of Verona, Verona, Italy, 5Fondazione IRCCS Istituto Nazionale Neurologico
‘‘Carlo Besta’’, Milan, Italy
Abstract
The disease phenotype of bovine spongiform encephalopathy (BSE) and the molecular/ biological properties of its prion
strain, including the host range and the characteristics of BSE-related disorders, have been extensively studied since its
discovery in 1986. In recent years, systematic testing of the brains of cattle coming to slaughter resulted in the identification
of at least two atypical forms of BSE. These emerging disorders are characterized by novel conformers of the bovine
pathological prion protein (PrP
TSE), named high-type (BSE-H) and low-type (BSE-L). We recently reported two Italian atypical
cases with a PrP
TSE type identical to BSE-L, pathologically characterized by PrP amyloid plaques and known as bovine
amyloidotic spongiform encephalopathy (BASE). Several lines of evidence suggest that BASE is highly virulent and easily
transmissible to a wide host range. Experimental transmission to transgenic mice overexpressing bovine PrP (Tgbov XV)
suggested that BASE is caused by a prion strain distinct from the BSE isolate. In the present study, we experimentally
infected Friesian and Alpine brown cattle with Italian BSE and BASE isolates via the intracerebral route. BASE-infected cattle
developed amyotrophic changes accompanied by mental dullness. The molecular and neuropathological profiles, including
PrP deposition pattern, closely matched those observed in the original cases. This study provides clear evidence of BASE as a
distinct prion isolate and discloses a novel disease phenotype in cattle.
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Introduction
Prion diseases, or transmissible spongiform encephalopathies
(TSEs), are mammalian neurodegenerative disorders of sporadic,
genetic, or infectious origin characterized by accumulation and
deposition of an abnormal isoform (PrP
TSE) of the cellular prion
protein (PrP
C) in the brain [1]. TSEs include a wide range of
animal and human disorders, such as BSE in cattle, scrapie in
sheep and goats, chronic wasting disease in deer and elk, and
Creutzfeldt-Jakob disease (CJD) in humans [1].
First identified in 1986 in the UK, BSE has been confirmed in
over 180,000 cases, although more than one million cattle have been
estimated to be infected [2]. Evidence of the spread of the BSE agent
across certain mammalian species, including humans, indicates that
this disease is a major animal and human public health issue [3–5].
Common neurological signs in cattle include apprehension,
hyperaesthesia, kicking, and pelvic limb ataxia, accompanied by
general signs such as reduced milk yield and loss of conditions. In all
cases, progression to behavioural, sensory and posture/movement
alterations led to death within a few months [6,7].
Early transmission studies showed that isolates from field BSE
cases and variant CJD (vCJD), its human counterpart, were all
caused by a single prion strain [4]. In addition, PrP
TSE from BSE
and vCJD cases exhibited a distinctive glycotype signature, with
high glycosylation site occupancy and similar electrophoretic
mobility of the unglycosylated protease-resistant PrP
TSE fragment
[8]. These PrP
TSE traits have been used as biochemical indicators
of the BSE prion strain.
Until recently, monitoring of BSE in cattle was accomplished by
passive surveillance and pathological confirmation of suspected
clinical cases. In 2001, the European Community imposed an active
surveillance system based on biochemical tests of brain tissues from
all slaughtered cattle over 30 months of age. This strategy led to the
recent identification of new PrP
TSE types, provisionally termed as
‘‘type-H’’ and ‘‘type-L’’ according to the electrophoretic migration
of the unglycosylated proteinase K-resistant PrP
TSE, which is higher
(BSE-H) or lower (BSE-L) than classical BSE (BSE-C) [9–11]. An
additional distinctive signature of type-H and type-L is the even
representation of di-, mono-, and unglycosylated PrP
TSE species.
In 2004, we described two aged asymptomatic Italian cattle of
Piemontese and Alpine brown breeds neuropathologically char-
acterized by the presence of PrP-amyloid plaques [12]. This new
pathological phenotype, named BASE, was characterized by
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thalamus, with relative sparing of the brainstem. The molecular
signature of BASE PrP
TSE was similar to that later detected in
BSE-L cases [11]. A feature shared between BASE, a condition
both well-defined molecularly and pathologically, and ‘‘L-type’’
cases, defined only on a molecular basis, is the older age of the
affected animals (approximately 12 years) as compared to BSE
cases (5–6 years).
Recent studies have shown that BASE and ‘‘L-type’’ isolates
exhibit similar biological properties upon transmission to Tgbov
XV, and have shorter incubation period and survival time than
BSE; these findings are suggestive of a single prion strain for BASE
and BSE-L [10,13]. In contrast, the H-type phenotype showed an
unusually long incubation period in Tgbov XV [10].
To date, all of the available demographic and molecular
evidence strongly suggests that H-type BSE and BASE-L represent
sporadic forms of bovine spongiform encephalopathies [14].
Human susceptibility to BASE has been suggested by
experimental transmission to primates and to PrP humanized
transgenic mice [14].
Here we inoculated cattle of different breeds with brain
homogenates from Italian BASE and BSE cases, in order to
assess the strain attributes and disease phenotype of the above
isolates in their natural hosts.
Results
Genetic analysis
All Friesian cattle were homozygous for six octapeptide repeat
copies, and three cattle carried a silent mutation at codon 78
(CAG/CAA). Four out of six Alpine brown cattle were
homozygous for six octapeptide repeat copies; one animal carried
6/7 and another 5/7 octapeptide repeat copies. Four different
silent mutations were found at codons 78 (CAG/CAA), 23 (CTC/
CTT), 95 (CCA/CCC), and 77 (GGT/GGC) in four cattle.
Homozygosity for 23 bp and 12 bp deletion alleles was present in
three Friesian cattle. Results of these genetic studies are
summarized in Table 1.
Incubation periods and clinical disease duration
A total of twelve cattle, two groups of three Alpine brown and
three Friesian, intracerebrally inoculated with either BSE or
BASE, developed neurological signs and were killed at the
terminal stage of disease (Table 2). In contrast, two saline
inoculated Friesian cattle are free of clinical signs at the time of
writing, i.e. 42 months post-inoculation. In BASE-treated cattle
the clinical disease duration was shorter than in BSE-inoculated
animals; however, caution in evaluating these differences is
dictated by the low number of experimental animals in addition
to the undetermined infectivity titre of the inocula.
Clinical features
In BSE-inoculated cattle, clinical signs at onset consisted of
behavioural changes and hypersensitivity. As the disease pro-
gressed, major clinical signs included aggressiveness, frequent
bellowing and head shaking, postural abnormalities, exaggerated
blink reflex, generalized cutaneous hyperaesthesia, and stimulus-
induced myoclonic jerks (Table 2 and Figure 1A and Video S1).
Conversely, early neurological signs in both Friesian and Alpine
brown cattle inoculated with BASE consisted of fasciculations of
gluteal muscles, a dull coat and postural and behavioural signs of
depression, including low head carriage, mild kyphosis, and
decreased alertness. With progression, muscle atrophy, beginning
in the gluteal region and progressing to the paravertebral region
and to other hind limb musculature became apparent (Figure 1B
and 1C). Fore-limb muscles were relatively spared (Video S2).
With the exception of the ‘‘downer’’ cattle, neither gait ataxia nor
difficulties in rising were observed throughout the disease course.
Cattle showed an exaggerated response to facial touch or pinch,
but not to light and sound stimuli. Observations via night filming
showed that BASE cattle were prone to sudden falls. One Friesian
cow (code # 254) showed a ‘‘downer’’ syndrome at onset.
Biochemical characterization and regional distribution of
PrP
TSE
Immunoblot analysis of proteinase K-treated (PK) brain
homogenates from each BSE- and BASE-infected cattle revealed
the presence of PrP
TSE in all sampled areas. However, all BSE-
challenged animals showed a di-glycosylated-dominant PrP
TSE
type, whereas in all BASE-inoculated cattle a mono-glycosylated-
dominant PrP
TSE type was detected. In addition, the molecular
mass of the PK-resistant unglycosylated fragment was identical to
that of the original inoculum in each animal (Figure 2A–2C). In
cattle infected with BSE, the highest amounts of PrP
TSE were
observed in the thalamus, basal ganglia, obex, olfactory areas and
hippocampus, whereas very low amounts were seen in cerebral
cortices and cerebellum (Figure 2D and 2E). Differently from BSE,
in BASE-infected cattle consistently high amounts of PrP
TSE were
observed in cerebral cortex, hippocampus, and cerebellum
(Figure 2F and 2G). In both groups, low amounts of PrP
TSE were
found in the spinal cord.
In all experimentally infected animals, no PrP
TSE was detected
in peripheral tissues, including cervical and mesenteric lymph
nodes, spleen, thymus, liver, lung, peripheral nerves and forelimb
and hind limb muscles, either by standard Western blot analysis or
following phosphotungstic acid precipitation.
Pathological and immunohistochemical findings
Typical neuropathological changes, including spongiosis and
gliosis were detected in all cattle (Figure S1 and S2). The
conventional lesion profile, based on vacuolation score, was similar
in BSE- and BASE-infected cattle; however, a more severe
Author Summary
For approximately two decades, bovine spongiform
encephalopathy (BSE), now termed classical BSE (BSE-C),
has been regarded as the only and exclusive prion disorder
affecting cattle. However, over the last 4 years, two
additional bovine prion strains, bovine amyloidotic spon-
giform encephalopathy (BASE, also named BSE-L) and BSE-
H, have been discovered and characterized in Canada, the
United States, Japan, and nine European countries, which
applied an active surveillance program on slaughtered
cattle. Although a total of 20 BSE-L and 16 BSE-H have
been reported to date, the disease phenotype of these
conditions remains largely unknown. Intriguingly, recent
evidence has been provided that the BSE-C and BASE
strains disclose converging properties after transmission to
inbred mice. Here, we show that intraspecies transmission
of BASE induces a disease phenotype characterized by
dullness and progressive amyotrophy, the latter highly
suggestive of a motor neuron disorder. This is at variance
with the over-reactivity and hypersensitivity, but not
muscle changes, observed in BSE-transmitted cattle. This
study confirms that BASE and BSE represent two distinct
prion disorders in cattle with diverging molecular features
and disease phenotypes.
Intraspecies Transmission of BASE
PLoS Pathogens | www.plospathogens.org 2 May 2008 | Volume 4 | Issue 5 | e1000075involvement of central grey matter (periaqueductal grey) and
rostral colliculus but not the vestibular nuclear complex were
observed in BASE-inoculated cattle as compared to BSE-
challenged animals, which showed severe involvement of the
putamen (Figure S1). Additional brain areas, including the
olfactory areas, amygdalae, hippocampi and dorsal horns of spinal
cords, were severely involved in both groups. Ventral and dorsal
roots did not show major pathological changes.
Friesian and Alpine brown muscle tissue was normal in BSE-
infected cattle (Figure 3A, 3C, 3E and 3G), whereas groups of
atrophic muscle fibers were observed in the gluteus medius
(Figure 3B, 3D and 3F) and, to a decreasing extent, in major psoas,
longissimus dorsi, and triceps brachii of BASE-infected cattle
(Figure 3H).
In BSE cattle, a synaptic-punctate and ‘‘glial-associated’’ stellate
pattern of PrP deposition was observed in different brain areas,
Table 1. Genetics of cattle.
Code Breed Inoculum Octarepeats Variation Codon 12-indel 23-indel
258 Friesian BSE 6/6 CAG/CAA 78 Q/Q 214:214 190:190
326 Friesian BSE 6/6 - Wt 202:202 167:167
329 Friesian BSE 6/6 CAG/CAA 78 Q/Q 202:214 167:190
254 Friesian BASE 6/6 CAG/CAA 78 Q/Q 214:214 190:190
259 Friesian BASE 6/6 - Wt 202:202 167:167
261 Friesian BASE 6/6 - Wt 202:202 167:167
330 Friesian Saline 6/6 - Wt 202:214 167:190
388 Friesian Saline 6/6 - Wt 202:214 167:190
340 Alpine brown BSE 6/6 CTC/CTT CAG/CAA 23 L/L 78 Q/Q 214:214 167:190
817 Alpine brown BSE 5/7 GGT/GGC CCA/CCC 77 G/G 95 P/P 214:214 167:190
844 Alpine brown BSE 6/7 CCA/CCC 95 P/P 214:214 190:190
816 Alpine brown BASE 6/6 - Wt 202:214 167:190
994 Alpine brown BASE 6/6 CAG/CAA 78 Q/Q 202:214 167:190
995 Alpine brown BASE 6/6 - Wt 214:214 190:190
doi:10.1371/journal.ppat.1000075.t001
Table 2. Clinical phenotype, incubation period and clinical duration in BSE- and BASE-infected cattle.
Inoculum/
Attack rate Code/Breed* Clinical signs at onset Progression of clinical signs
Incubation period
(days)
Clinical duration
(days)
BSE 100% 258-F Nervousness,
hypersensitivity
Apprehension, hypersensitivity to tactile,
acoustic and visual stimuli
524 180
326-F 660 45
329-F 640 150
Mean: 608 Mean: 125
340-Ab Nervousness,
hypersensitivity
Apprehension, hypersensitivity to tactile,
acoustic and visual stimuli
503 120
817-Ab 514 180
844-Ab 493 60
Mean: 503 Mean: 120
BASE 100% 254-F Dullness Downer cattle 461 10
259-F Dullness, amyotrophy Dullness, amyotrophy, hypersensitivity
to facial tactile stimuli
480 60
261-F 470 30
Mean: 470 Mean: 33
816-Ab Dullness, amyotrophy Dullness, amyotrophy, hypersensitivity
to facial tactile stimuli
551 30
994-Ab 530 60
995-Ab 525 105
Mean: 535 Mean: 65
* F denotes Friesian; Ab denotes Alpine brown.
doi:10.1371/journal.ppat.1000075.t002
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cerebellum, medulla, and spinal cord (Figure 4A and inset, 4E,
4G, 4I and inset). Conversely, in BASE-inoculated cattle,
abundant amyloid PrP plaques were observed in subcortical white
matter and in deep grey nuclei, as observed in natural BASE cases
(Figure 4B and inset, 4F; and Figure S2 and S3). No PrP plaques
were seen in the olfactory glomeruli, the cerebellum or the spinal
cord (Figure 4I and 4J). Neurons from BSE cattle showed
intracellular PrP deposition in contrast to the membrane-
associated deposits observed in neuronal cells of BASE cattle
(Figure 4C and 4D). These patterns of PrP neuronal staining were
also seen in ventral horn neurons of the spinal cord (Figure 4I and
J insets) and in the dorsal root ganglion cells (data not shown). No
PrP staining was detected in the peripheral nerves and muscles.
Discussion
In the present work, we demonstrate that BSE and BASE
isolates maintain distinct biological properties and induce different
disease phenotypes after transmission in their natural host. The
similarity of the molecular typing differences between BASE and
BSE PrP
TSE in Friesian and Alpine Brown cattle also supports the
notion that the two conditions are caused by different prion
strains.
Cattle inoculated with BASE developed a syndrome character-
ized by progressive muscle atrophy and behavioural changes.
Amyotrophic changes were preceded by fasciculations, findings
denoting a lower motor neuron deficit. The absence of anorexia or
difficulty in feeding and swallowing suggests that amyotrophy may
be caused by motor neuron dysfunction and, therefore, not
indicative of a generalized wasting syndrome, such as that
observed in chronic wasting disease [15]. Consistent with clinical
findings of lower motor neuron involvement, pathological
examination of muscle tissues disclosed groups of atrophic fibers
more frequently detected in proximal than distal hind limb
muscles. However, there was no convincing loss of ventral horn
neurons.
Pathogenic mechanisms leading to motor neuron dysfunction
remain unknown; however, the role of pathological PrP deposition
at the plasma membrane of motor neurons or a loss of PrP
function, as observed in experimental models of amyotrophic
lateral sclerosis, cannot be ruled out [16].
Clinical signs of motor neuron dysfunction, including stiffness,
posterior paresis with ‘‘clonic spasms of muscle bundles’’ [17] and
generalized weakness, accompanied by severe lethargy and ataxia,
were previously reported in cattle experimentally infected with
American strains of sheep scrapie (either at first or at second
passage). Cattle inoculated with pre-1975 and post-1990 sources of
sheep scrapie from the UK presented similarly with ataxia and
weakness and most showed dullness with low head carriage and
did not over react to external stimuli [17–19]. While the clinical
characterization described previously in cattle infected with
scrapie is suggestive of upper and lower motor neuron involve-
ment, results obtained in BASE cattle point to lower motor neuron
dysfunction or to peripheral neuropathy as the cause of
amyotrophic changes.
In contrast to the amyotrophic changes observed in BASE-
inoculated cattle, animals inoculated with BSE presented a
disorder characterized by apprehension and hypersensitivity to
external stimuli, overlapping clinical features described in early
accounts of UK BSE [20].
Molecular features of PrP
TSE from BASE and BSE donor cattle
were preserved with high fidelity in recipient animals. In
particular, the conformation of PrP
TSE, as assessed by the
electrophoretic motility of the core fragment, and the glycosylation
status were indistinguishable in recipient animals of different
breeds compared to the original inocula. These PrP
TSE traits were
maintained in all cortical and subcortical investigated brain
regions.
Taken together, PrP
TSE molecular traits and PrP
TSE regional
distribution showed distinct patterns in the two groups of animals,
supporting the notion of two different prion strains, as also
suggested by results from experimental transmission to transgenic
mice expressing bovine PrP [10,13].
Differences between BASE- and BSE-inoculated animals were
also observed at the neuropathological and immunohistochemical
A
B
C
Figure 1. BSE and BASE infected cattle. (A) BSE Friesian (#258) at
670 d.p.i., (B) BASE Alpine brown (#995) 600 d.p.i., and (C) BASE
Friesian (#261) 585 d.p.i. BASE-infected cattle show muscle atrophy
particularly severe at the hind limbs and pelvic girdle (B,C), while in BSE-
challenged cattle (A) musculature is apparently normal.
doi:10.1371/journal.ppat.1000075.g001
Intraspecies Transmission of BASE
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changes were observed, as a likely effect of early disease stage,
markedvacuolation was seen inBASE-inoculatedcattle with a lesion
profile divergent from that seen in BSE-treated animals in at least
four regions. Indeed, extensive vacuolar pathology was seen in the
hindbrain of BASE-inoculated cattle, whereas severe involvement of
the putamen was a distinguishing feature in the BSE group.
The divergent biological properties of the two strains were
further confirmed by the different patterns of PrP deposition,
indistinguishable from those patterns seen in naturally occurring
BSE and BASE. Moreover, the distinct neural and microglial cells
involved in the two groups and the subcellular sites of PrP
accumulation denote a different trafficking and propagation of
PrP.
Figure 2. Biochemical analysis and regional distribution of PrP
TSE in BSE and BASE experimentally infected cattle. (A) Immunoblot
with 6H4 of proteinase K-treated brain homogenates from BSE and BASE inocula (abbreviated as i) (lanes 1 and 4) from Friesian (abbreviated as F) and
Alpine brown (abbreviated as Ab) inoculated with BSE (lanes 2 and 3, respectively), and BASE (5 and 6, respectively); (B) samples after PNGase F-
treatment. (C) Relative proportions of the three PrP
TSE glycoforms in BSE and BASE inocula and in infected cattle. (Standard error bars correspond to
variations of PrP
TSE glycoform in the inocula, as determined in six replicates. On the contrary, in Friesians and in Alpine browns cattle inoculated with
BSE and BASE determination was performed on at least six different brain areas from each animal) (D–G) Brain regional distribution of PrP
TSE in BSE (D
and E) and BASE (F and G) infected cattle. Values below each lane correspond to the relative percentage of PrP
TSE normalized against thalamus. MW,
molecular weights; kDa: kilodaltons; OD: optical density.
doi:10.1371/journal.ppat.1000075.g002
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recapitulated the key neuropathological hallmarks observed in
these naturally occurring cattle TSEs. This is at variance with the
alternate patterns of PrP
TSE depositions seen in inoculated Tgbov
XV mice, i.e., uni- and multicentric plaques in BSE-challenged
animals and diffuse/focal PrP deposition, but not amyloid plaques,
in BASE-inoculated mice [10,13].
We recently showed that in TgBov XV mice challenged with
the same inocula used in the present study, BASE-inoculated mice
had significantly shorter incubation periods and survival times
than BSE-inoculated mice, consistent with results from another
laboratory [10,13]. This effect was not influenced by any species
barrier phenomenon and is therefore likely to be strain-dependent.
An exception to diverging phenotypic characteristics observed in
BSE- and BASE-inoculated cattle was the incubation time
observed for BSE-inoculated Alpine brown (but not BSE-treated
Friesian animals) which did not significantly differ from times
assessed for BASE-inoculated Friesian and Alpine brown cattle.
However, the small number of investigated animals and the
individual variability in incubation times dictate caution in the
interpretation of these data. In contrast, the breed-associated effect
in BASE-inoculated cattle, with significantly shorter incubation
periods and survival times in Friesian than in Alpine brown,
suggests that disease-modifier genetic loci other than known PRNP
polymorphisms could be relevant to both of these parameters.
While it is now clear that vCJD originated from human
exposure to BSE, it is still uncertain whether emerging cattle
TSEs, including BASE, or L-BSE, and H-BSE have infected
humans or to which extent they can be potentially dangerous for
human and animal health. Recent experimental data show that
Figure 3. Histology and ATPase staining of muscle sections from gluteus medius of BSE and BASE cattle and major psoas of BASE
cattle. (A) Friesian cattle challenged with BSE and (B) BASE; (C, E) BSE- and (D, F) BASE-infected Alpine brown cattle. As opposed to the normal
appearance of muscle tissue in BSE-infected cattle, groups of atrophic muscle fibers are seen in BASE-inoculated cattle. Hematoxylin and eosin
staining (A–D scale bars 50 mm; E, F scale bars 20 mm). (G, H) Myosin ATPase staining of major psoas from BASE-infected cattle (code breed g, 995; h,
994) after preincubation at pH 4.6, shows that atrophic muscle fibers are both types I and II (scale bars 50 mm).
doi:10.1371/journal.ppat.1000075.g003
Intraspecies Transmission of BASE
PLoS Pathogens | www.plospathogens.org 6 May 2008 | Volume 4 | Issue 5 | e1000075Figure 4. PrP deposition in the brain and spinal cord of BSE and BASE infected cattle. (A, C, E, G, I) BSE infected cattle, showing synaptic-
punctuate and stellate patterns in (A) the frontal cortex (scale bar 100 mm), detail of stellate labelling (inset, scale bar 20 mm) and (C) detail of granular
staining in the perikaryon of a cortical neuron (scale bars 20 mm); (D, D, F, H, J) BASE cattle showing (B) a diffuse synaptic-punctuate staining and
abundant PrP plaques in the deeper cortical layers and in the white matter of frontal cortex (arrow, scale bar 100 mm), detail of a plaque (inset, scale
bar 20 mm), and (D) of a cortical neuron (scale bars 20 mm). The different patterns of PrP deposition, in all BSE- and BASE-infected cattle, were also
observed in the thalamus (E, F) and in the cerebellum (G, H), with the exception of amyloid plaques which were not observed in the cerebellum (scale
bars 100 mm). PrP deposition in spinal cord mainly occurred at the level of Rexed laminae I–III, in both BSE (I) and BASE (J) infected cattle (scale bars
500 mm); motor neurons, indicated by arrows, displayed distinct patterns of PrP deposition in BSE (inset, scale bar 20 mm) and in BASE (inset, scale bar
20 mm) infected cattle (F99, 1:5000).
doi:10.1371/journal.ppat.1000075.g004
Intraspecies Transmission of BASE
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to TgOv mice; in the latter, BASE transmits at first passage with a
100% attack rate, as opposed to cattle BSE that transmits with a
low attack rate [21]. Moreover, transmitted BASE shows shorter
incubation periods than BSE in Cynomolgus monkeys [14].
Paradoxically, while BASE is efficiently transmitted at first passage
and with a high attack rate to 129 Met/Met Tg humanized mice
[22], human transgenic lines of all genotypes at codon 129 are
resistant to BSE transmission [22,23]. Taken together, these data
might suggest that the BASE agent could transmit to humans more
efficiently than the BSE agent.
Materials and Methods
Animal care
All procedures involving animals and their care were conducted
in conformity with national and international laws and policies
(EEC Council Directive 86/609, OJL358, 1, 12 December 1987;
Italian Legislative Decree 116/92, Gazzetta Ufficiale della
Repubblica Italiana 10, 18 February 1992; and Guide for the Care
and Use of Laboratory Animals, U.S. National Research Council,
1996), and the study was approved by the authors’ Institutional
Review board.
Bovine PrP Gene Determination
PRNP ORF amplification, sequencing and determination of the
octapeptide repeat copy number was performed as previously
described [12]. Polymorphisms of the 12-bp indel, located within
intron 1, and 23-bp indel, located in the promoter region, were
determined as previously reported [24]. Primer pairs 59-
CCTGTTGAGCGTGCTCGT/59-ACCTGCGGCTCCTCTACC-39
and 59-GAAGTCACGTGAAGGCACT-39/59-CAAAGAGTT-
GGACAGGCACA-39 were used to amplify the 12-bp indel
(202 bp/214 bp) and 23-bp indel (167 bp/190 bp), respectively,
as described above. PCR was performed as 30 cycles of 30 sec at
94uC, 30 sec at 55uC and 45 sec at 72uC. High resolution agarose
(3.5%) gel electrophoresis was used to visualise the allelic PCR
products whose specificity and length was also confirmed by direct
sequencing with the same primer used for the PCR described
above.
Inocula
10% brain homogenates from the thalamus of a BSE-affected
Friesian (code #128204) and a BASE-affected Piemontese (code
#1088) were prepared in phosphate-buffered saline. These cattle
carried the same PrP genotype with six octapeptide repeats, and
were extensively studied in our previous work [12]. BSE and
BASE inocula were prepared to obtain a comparable amount of
PrP
TSE as assessed by Western blot analysis with the 6H4 anti-PrP
monoclonal antibody (Prionics).
Inoculation of cattle
Eight Friesian and six Alpine brown cattle (4 months old) were
purchased from Italian herds in which no cases of BSE had ever
been recorded. All calves were free of neurological signs. Prior to
inoculation, animals remained in the new environment for one
month for adaptation. Inoculation was carried out using a semi-
stereotaxic technique in surgical aseptic conditions. Calves were
anesthetized with xylazine (50 mg/kg), a midline incision was
made at the junction of the parietal and frontal bones, and a 1-mm
hole was drilled through the calvarium. The inoculum was injected
into the frontal lobe via a 22-gauge 9-cm-long disposable needle
while the needle was withdrawn. Two groups of animals, each
comprising three Friesians and three Alpine brown cattle, were
inoculated with 1 milliliter of 10% brain homogenate from BSE-
and BASE-affected animals, respectively. Conversely, two Frie-
sians cattle were challenged with 1 milliliter of phosphate buffered
saline and used as controls. To avoid potential cross-contamina-
tion, BSE and BASE transmission experiments were performed on
different days and the facility was decontaminated with 10%
sodium hypochlorite solution after each inoculation.
Clinical assessment
Clinical evaluations were comprised of a bi-weekly observation
by the veterinarian and two daily observations by animal
husbandry staff who reported any observed motor and/or
behavioural changes. For assessment of the gait cows were walked
along the corridor outside the pen. The cattle were filmed nightly
with closed circuit television monitoring to record signs of disease
that may not have been observed during the day. Once a month, a
veterinarian trained in neurology examined each cattle by
conventional neurological scale evaluations [25,26]. Animals were
considered symptomatic when they showed two of the following
neurological signs observed in two separate consecutive examina-
tions: abnormal behaviour, abnormal posture, aberrant reactions,
or hyperreactivity to sensitive stimuli, light and sound.
Postmortem investigations
Cattle at the terminal stage were euthanized with pentobarbital
administered intravenously. Peripheral organs, including cervical
and mesenteric lymph nodes, spleen, thymus, liver, lung,
peripheral nerves and forelimb and hind limb muscles (m. triceps
brachii, m. longissimus dorsi, m. gluteus medius and m.major psoas), were
sampled and each sample was divided equally; one portion was
fixed in 4% buffered formaldehyde for H&E stain and PrP
immunohistochemistry, and the other was frozen. Serial 10-mm-
thick muscle cryosections were stained with H&E and adenosine
triphosphatase (ATPase), after pre-incubation at pH 4.3, 4.6 and
10.4. Nervous tissue was removed in a separate area to avoid cross-
contamination. The fixed half of the brain sample was used for
neuropathological examination, while the frozen brain sample was
stored at 280uC for biochemical analyses. The spinal cord was
sampled at cervical, thoracic, lumbar and sacral levels and sections
were fixed in 10% buffered formaldehyde. The remaining tissue
was frozen at 280uC for further studies.
Immunoblot analysis
From each neural tissue sample, including optic nerve, olfactory
bulb, frontal cortex, occipital cortex, hippocampus, nucleus
caudatus, putamen, globus pallidus, thalamus, cerebellum, obex,
and cervical, thoracic, lumbar and sacral spinal cord, 100 mg of
wet tissue was homogenized in 9 volumes of lysis buffer (100 mM
sodium chloride/10 mM EDTA/0.5% Nonidet P-40/0.5% sodi-
um deoxycholate/10 mM Tris, pH 7.4) and digested with 50 mg/
ml of proteinase K (Boehringer Mannheim) for 1 h at 37 uC.
Digestion was blocked by the addition of phenylmethylsulfonyl
fluoride at 2 mM. For deglycosylation, proteinase K-digested
samples were deglycosylated with recombinant peptide N-glyco-
sidase F (PNGase F) according to manufacturer’s instructions
(Boehringer Mannheim). Samples, equivalent to 400 mg of wet
tissue, were resolved on 13% polyacrylamide gels and then
transferred onto PVDF membrane (Immobilon P; Millipore,
Bedford MA) for 2 hours at 60V. Membranes were blocked with
1% non-fat dry milk in TBST (10 mM Tris/150 mM sodium
chloride/0.1% Tween-20, pH 7.5) for 1 hour at 37uC and
incubated overnight at 4uC with anti-PrP monoclonal antibody
6H4 (Prionics) diluted to 1/5,000. Blots were developed using the
Amersham enhanced chemiluminescence (ECL) system, as
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film. Films were scanned by using a densitometer (GS-710,
Biorad), calculating the relative amounts of PrP
Sc in a semiquan-
titative manner.
To enhance PrP
TSE detection, extraneural tissues, including
cervical and mesenteric lymph nodes, spleen, thymus, liver, lung,
peripheral nerves and forelimb and hind limb muscles, that were
negative on a standard immunoblot were subjected to phospho-
tungstic acid (PTA) precipitation and analyzed by Western blot, as
previously described [27]. Briefly, 100 mg of wet tissue were
homogenized in nine volumes of 2% sarkosyl in phosphate-
buffered saline, pH 7.4. Cellular debris were removed by
centrifugation at 1,000 rpm for 2 minutes and samples were
incubated for 30 minutes at 37uC with constant agitation in
phosphate-buffered saline containing 50 units/mL Benzonase and
1 mmol/L magnesium chloride. Subsequently, samples were
adjusted to 0.3% sodium phosphotungstic acid, incubated at
37uC for 30 minutes and centrifuged at 14,000 rpm for 30 min-
utes. The supernatant was saved, and the pellet dissolved in 20 ml
phosphate-buffered saline, pH 7.4, containing 0.1% sarkosyl. The
supernatant and the pellet were adjusted to a final concentration of
20 mg of proteinase K per milliliter and incubated at 37 uC for
30 minutes.
Neuropathology and PrP immunohistochemistry
Three-mm thick samples were embedded in paraffin after
decontamination with 98% formic acid for 1 hour. The paraffin-
embedded blocks selected for the study included coronal sections
at the level of the olfactory bulb, the frontal, parietal and occipital
cortices, the pyriform lobus, hippocampus, striatum, thalamus,
brainstem, sagittal sections through the cerebellum and spinal cord
at cervical, thoracic, lumbar and sacral levels. Histological sections
were deparaffinized, rehydrated, and stained with hematoxylin
and eosin. Additional sections were stained with thioflavin S. The
distribution of spongiosis, was determined by using a conventional
lesion profile, which allows to characterize strain tropism and to
compare the present results with those of previous studies on field
and experimental BSE [28]. The definition of each score was
performed by three independent observers blinded to the animal
identification, as follows: 0 no vacuolation, 1 a few vacuoles
(minimum 3 per field610 objective), 2 several vacuoles evenly
distributed, 3 moderate numbers or many vacuoles evenly
distributed, and 4 numerous vacuoles some of which coalescing,
as previously described [28].
For immunohistochemical study, sections obtained form
nervous and extraneural tissues, were rehydrated and treated
with 98% formic acid for 20 min at room temperature, followed
by hydrated autoclaving in distilled water at 121uC for 30 min.
After rinsing, sections were incubated overnight at 4uC with anti-
PrP monoclonal antibody F99/97.6.1 (VMRD, inc.; diluted to 1/
1,000), recognizing a conserved epitope (QYQRES) on the cattle
PrP. Subsequent antibody detection was carried out using a
biotinylated goat anti-mouse secondary antibody diluted to 1/200
for 20 min (Vector Laboratories, Burlingame, CA) at room
temperature, followed by the avidin-biotin-peroxidase complex
(Vectastain ABC kit; Vector Laboratories) according to manufac-
turer’s protocol. Immunoreactivity was visualized using 3,39-
diaminobenzidine as chromogen.
Supporting Information
Figure S1 Lesion profiles and pathological changes in BSE and
BASE challenged cattle. 1. Nucleus of the solitary tract. 2. Nucleus
of the spinal tract of the trigeminal nerve. 3. Hypoglossal nucleus.
4. Vestibular nuclear complex. 5. Cochlear nucleus. 6. Cerebellar
vermis. 7. Central grey matter. 8. Rostral colliculus. 9. Medial
geniculate nucleus. 10. Hypothalamus. 11. Nucleus dorsomedialis
thalami. 12. Nucleus ventralis lateralis thalami. 13. Frontal cortex.
14. Septal nuclei. 15. Caudate. 16. Putamen. 17. Claustrum; (A,B
and C,D) represent the histopathological changes in areas 7 and
16, respectively, included in the lesion profiles in BSE (A and C)
and BASE (B and D) infected cattle; (E and F) hippocampus,
which is not included among the brain areas of lesion profile,
shows consistent spongiform changes in both BSE (E) and BASE
(F) infected cattle (scale bars 100 mm).
Found at: doi:10.1371/journal.ppat.1000075.s001 (2.93 MB TIF)
Figure S2 Immunocytochemistry for GFAP in BSE- (A, C, E)
and BASE-infected cattle (B, D, F). Central grey matter (7) and
frontal cortex (13) show a higher degree of gliosis in BASE,
whereas the putamen is more affected in BSE-infected cattle (17;
scale bars 75 mm).
Found at: doi:10.1371/journal.ppat.1000075.s002 (6.18 MB TIF)
Figure S3 Tinctorial properties of amyloid plaques in BASE.
Fluorescent Kuru-plaques in the frontal cortex of a Friesian (code:
# 259) and Alpine brown (code: # 994) BASE-infected cattle (A,
B; thioflavin S method).
Found at: doi:10.1371/journal.ppat.1000075.s003 (0.49 MB EPS)
Video S1 Clinical phenotype of BSE-infected cattle.
Found at: doi:10.1371/journal.ppat.1000075.s004 (2.24 MB
MOV)
Video S2 Clinical phenotype of BASE-infected cattle.
Found at: doi:10.1371/journal.ppat.1000075.s005 (3.39 MB
MOV)
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